 | Issue navigator |
|
|
Contents of Volume 9 Suppl 1
VII Madrid Breast Cancer Conference: Changes in the treatment of breast cancer
Meeting abstracts
Madrid, Spain. 20  22 June 2007 The organisers would like to thank Novartis for funding publication of this abstract supplement.
|
Poster presentation
Prognostic factors for the node-negative breast cancers
B-W Park, J-H Kim, K-S Kim, KS Lee
Breast Cancer Research 2007, 9(Suppl 1):P1 (19 June 2007)
[Full text] [PDF] [PubMed] [Related articles]
Poster presentation
Retreatment with trastuzumab in Her2-positive metastatic breast cancer patients: a clinical study
F Carabantes-Ocón, E Saez-Lara, L Burgos-Garcia, E Villar-Chamorro, A Casaus-Hazañas, S Luna, C Martínez
Breast Cancer Research 2007, 9(Suppl 1):P2 (19 June 2007)
[Full text] [PDF]
Poster presentation
Do breast cancer tumours downsize as well as downgrade with neoadjuvant chemotherapy?
M Dani, J McDonnell, S Karp, V Jaffe
Breast Cancer Research 2007, 9(Suppl 1):P3 (19 June 2007)
[Full text] [PDF]
Poster presentation
Saline instillation into the cavity after conservation surgery for breast cancer is a safe way of improving cosmesis
M Dani, T Tahmid, J McDonnell, V Jaffe
Breast Cancer Research 2007, 9(Suppl 1):P4 (19 June 2007)
[Full text] [PDF]
Poster presentation
A safety and efficacy study of bleomycin sulfate and electroporation in patients with metastatic or locally recurrent breast cancer
V Paramanov, O Tyurin, S Polenkov, PM Goldfarb
Breast Cancer Research 2007, 9(Suppl 1):P5 (19 June 2007)
[Full text] [PDF]
Poster presentation
Predictive value of HER2 expression for the selection of adjuvant chemotherapy in breast cancer patients
A Hegmane, U Vikmanis
Breast Cancer Research 2007, 9(Suppl 1):P6 (19 June 2007)
[Full text] [PDF]
Poster presentation
Axillary study before surgery in patients with breast cancer
M Izquierdo, R Fabregas, J Feu, L Lopez Marin, B Navarro, C Ara, M Cusido, F Tresserra
Breast Cancer Research 2007, 9(Suppl 1):P7 (19 June 2007)
[Full text] [PDF]
Poster presentation
Resveratrol downregulates acetyl-CoA carboxylase alpha and fatty acid synthase by activating AMP-activated protein kinase and suppressing the mammalian target of rapamycin signal pathway
S Yoon, B-W Park, K-S Kim
Breast Cancer Research 2007, 9(Suppl 1):P8 (19 June 2007)
[Full text] [PDF]
Poster presentation
Partial breast irradiation with an electron beam for patients submitted to conservative surgery
MAC Maia, MM Netto, MS Maciel, JC Donoso, JV Salvajoli, ACA Pellizzon, RC Fogaroli, KW Bocalletti, C Tanous
Breast Cancer Research 2007, 9(Suppl 1):P9 (19 June 2007)
[Full text] [PDF]
Poster presentation
Positive axillary lymph node metastases in T1T3 breast cancer: prognostic value of extracapsular extension
S Maksimovic, Z Gojkovic, M Opric
Breast Cancer Research 2007, 9(Suppl 1):P10 (19 June 2007)
[Full text] [PDF]
Poster presentation
Study of the combination gemcitabine and trastuzumab in the treatment of HER2+ metastatic breast cancer
S Menjón-Beltrán, R Olivencia-Dueso, E González-Jiménez, MJ Titos
Breast Cancer Research 2007, 9(Suppl 1):P11 (19 June 2007)
[Full text] [PDF]
Poster presentation
Clinical role of trastuzumab in metastatic breast cancer: experience of a center
S Menjón-Beltrán, R Olivencia, E Gonzalez
Breast Cancer Research 2007, 9(Suppl 1):P12 (19 June 2007)
[Full text] [PDF]
Poster presentation
BRCA1a has antitumor activity in triple-negative breast cancers
C Yuli, N Shao, G Oprea-llies, J Okoli, ESP Reddy, VN Rao
Breast Cancer Research 2007, 9(Suppl 1):P13 (19 June 2007)
[Full text] [PDF]
Poster presentation
Diagnosis of familial breast cancer by multiplex PCR and clinical parameters
H Rassi
Breast Cancer Research 2007, 9(Suppl 1):P14 (19 June 2007)
[Full text] [PDF]
Poster presentation
Novel method of sentinel lymph node detection in malignant tumors using preparation 'UNIMAG'
B Surguladze, R Zhorzoliani, T Tskitishvili
Breast Cancer Research 2007, 9(Suppl 1):P15 (19 June 2007)
[Full text] [PDF]
Poster presentation
Frequency of febrile neutropenia in patients treated with taxane/epirubicine and colony-stimulating growth factors for breast cancer: comparison of filgrastim/lenograstim with pegfilgrastim
W Schippinger, R Holub, N Dandachi, T Bauernhofer
Breast Cancer Research 2007, 9(Suppl 1):P16 (19 June 2007)
[Full text] [PDF]
Poster presentation
Comparison of side-effect profiles during active treatment versus follow-up in the International Breast Cancer Intervention Study I tamoxifen prevention trial
I Sestak, R Edwards, A Howell, J Cuzick
Breast Cancer Research 2007, 9(Suppl 1):P17 (19 June 2007)
[Full text] [PDF]
Poster presentation
Minimal residue disease (MRD)
A Zaidi, G Tripuraneni, S Weller, B Ward, HD Sinnett, RC Coombes, MJ Slade
Breast Cancer Research 2007, 9(Suppl 1):P18 (19 June 2007)
[Full text] [PDF]
Poster presentation
Algorithm for identification of individuals with hereditary predisposition to breast cancer and other breast cancer-associated forms of malignant neoplasms
IV Zalutsky, NN Antonenkova, GM Porubova
Breast Cancer Research 2007, 9(Suppl 1):P19 (19 June 2007)
[Full text] [PDF]
Poster presentation
Identification of individuals with hereditary predisposition to breast cancer and other breast cancer-associated forms of malignant neoplasms: data of the Belarusian Cancer Registry
IV Zalutsky, NN Antonenkova
Breast Cancer Research 2007, 9(Suppl 1):P20 (19 June 2007)
[Full text] [PDF]
| |
|  |
